查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684325

藥物-設備組合產品市場，按產品類型、按應用、按最終用戶、按技術、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Drug-Device Combination Products Market, By Product Type, By Application, By End-User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 383 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年藥物設備組合產品市場規模價值為 139,489.42 百萬美元，2025 年至 2032 年期間的複合年成長率為 8.9%。

藥械組合產品市場-市場動態

預計對微創藥物輸送設備的需求不斷增加以及糖尿病等慢性疾病的盛行率不斷上升將推動市場的發展。

隨著糖尿病、心血管疾病和呼吸系統疾病等疾病的發生率上升，藥物-器械組合產品的使用率顯著增加，以提高治療效果、患者依從性和整體醫療保健效果。隨著需要長期藥物管理的患者數量不斷增加，藥物-設備組合產品（例如胰島素幫浦、自動注射器和預充式注射器）的使用正在增加，以提高治療效果和患者依從性。美國糖尿病協會進行的一項研究涉及 432 個糖尿病中心的 96,547 名第 1 型糖尿病患者。此外，技術的進步以及監管支持和批准的增加可能會為市場擴張帶來機會。然而，高昂的製造和開發成本可能會對市場成長構成挑戰。

藥物-設備組合產品市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 8.9%

根據產品類型細分，經皮貼片預計將在 2024 年佔據最大市場佔有率

根據應用細分，心血管是 2024 年領先的應用

根據最終用戶細分，醫院是 2024 年領先的最終用戶

從地區來看，北美是 2024 年的主要收入來源

藥物-設備組合產品市場-細分分析：

全球藥物設備組合產品市場根據產品類型、應用、最終用戶和地區進行細分。

根據產品類型，市場分為五個部分：藥物洗脫支架、輸液幫浦、吸入器、骨科組合產品、傷口護理組合產品、光動力治療設備、經皮貼片、抗菌導管等。經皮貼片處於市場成長的最前沿。在經皮給藥系統創新的推動下，藥物-設備組合產品市場正經歷顯著擴張。經皮貼片是該領域的重要組成部分，與口服或注射劑相比，它有助於控制藥物釋放，增強患者依從性，並減輕全身副作用。 FDA 和 EMA 對下一代貼片的監管批准正在促進市場成長。此外，生物相容性和可生物分解的貼片的開發旨在減少皮膚刺激。

根據應用，市場分為四個主要類別：心血管、糖尿病、癌症治療、呼吸系統疾病和其他。心血管領域引領市場。藥械組合產品市場正在經歷大幅成長，尤其是在心血管領域，這得益於心臟病發病率的上升以及對複雜、微創治療方案的需求不斷成長。這些產品將藥品與醫療器材結合在一起，以改善治療效果、增強患者依從性並縮短住院時間。

根據最終用戶，市場分為兩個部分：醫院、門診手術中心和其他。醫院部門是該市場的領導部門。藥械組合產品市場正在經歷快速成長，其中醫院對先進、高效、微創治療方案的需求不斷增加，對這一趨勢做出了巨大貢獻。這些產品將藥品與醫療器材結合在一起，從而提高治療效果、患者依從性和醫院內的運作效率。高精度藥物管理對於重症監護患者至關重要，因此醫院成為這些組合產品的主要最終用戶，這些產品對於重症監護、外科手術和慢性病管理至關重要。此外，醫院擴大採用微創技術，這導致藥物洗脫支架和基於導管的藥物傳輸系統的使用增加。

藥物設備組合產品市場-地理洞察

北美憑藉其先進的醫療保健基礎設施和大量的研發活動引領市場成長。該地區受益於強力的監管框架和優惠的報銷政策，這進一步促進了市場成長。 2022年，美國醫療衛生支出上漲4.1%，達4.5兆美元，人均醫療保健支出1,3,493美元。根據美國醫學協會報告，這一成長率與疫情前的數據一致。同時，隨著慢性病發生率的上升，中國、日本、印度等國對藥械組合產品的需求也日益成長。此外，阿拉伯聯合大公國和南非因加大對醫療創新的投資而成為重要的市場。

藥物-設備組合產品市場-競爭格局：

藥物-設備組合產品市場競爭激烈，主要參與者專注於技術進步、監管批准和策略合作，以加強其市場地位。推動這項競爭的因素包括對先進藥物輸送系統的需求不斷成長、慢性病發病率不斷上升以及對微創治療的偏好日益增加。各公司透過開發能夠提高患者便利性和治療效果的下一代藥物-設備組合來展開競爭。由於醫療保健投資的增加，各大公司正在向新興市場（亞太地區、拉丁美洲和中東）擴張。

最新動態：

2024年5月，諾華宣布已達成協議，收購位於麻薩諸塞州沃特敦的臨床前階段的生技公司Mariana Oncology。該公司專門開發創新放射性配體療法 (RLT)，旨在解決存在重大未滿足醫療需求的癌症。

目錄

第 1 章：藥物設備組合產品市場概覽

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 藥物設備組合產品市場片段（依產品類型）
    • 藥物設備組合產品市場片段（依應用）
    • 藥物設備組合產品市場片段（依最終用戶）
    • 藥物設備組合產品市場（按國家/地區）摘要
    • 藥物設備組合產品市場片段（按地區）
  • 競爭洞察

第 3 章：藥物設備組合產品關鍵市場趨勢

  • 藥物設備組合產品市場促進因素
    • 市場促進因素的影響分析
  • 藥物設備組合產品市場限制
    • 市場限制的影響分析
  • 藥物設備組合產品市場機會
  • 藥械組合產品市場未來趨勢

第 4 章：藥物器材組合產品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第 5 章：藥物設備組合產品市場：地緣政治緊張局勢升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：藥物器材組合產品市場格局

  • 2024 年藥物設備組合產品市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：藥物設備組合產品市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 藥物洗脫支架
    • 點滴幫浦
    • 吸入器
    • 骨科組合產品
    • 傷口護理組合產品
    • 光動力治療儀
    • 經皮貼劑
    • 抗菌導管
    • 其他

第 8 章：藥物設備組合產品市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 心血管
    • 糖尿病
    • 癌症治療
    • 呼吸系統疾病
    • 其他

第 9 章：藥物設備組合產品市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 門診手術中心
    • 其他

第 10 章：藥物設備組合產品市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美藥械組合產品主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（依產品類型）
    • 北美市場規模與預測，按應用分類
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲藥械組合產品主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（依產品類型）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區藥物器材組合產品主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲藥物器械組合產品主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲的藥物設備組合產品主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模及預測（依產品類型）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-藥物設備組合產品產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Medtronic Plc
    • Boston Scientific Corp.
    • Becton
    • Dickinson and Company
    • Novartis AG
    • GlaxoSmithKline plc
    • AbbVie Inc. (Allergan)
    • WL Gore & Associates Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4846

REPORT HIGHLIGHT

Drug Device Combination Products Market size was valued at US$ 139,489.42 Million in 2024, expanding at a CAGR of 8.9% from 2025 to 2032.

Drug-Device Combination Products represent innovative therapeutic and diagnostic solutions that integrate a pharmaceutical agent with a medical device into a unified system. These products aim to improve the efficiency of drug delivery and facilitate the controlled administration of medications. In response to the increasing demand from patients for more convenient and accessible treatment alternatives, pharmaceutical companies are progressively investing in sophisticated delivery mechanisms, including prefilled syringes, auto-injectors, and on-body injectors. Concurrently, regulatory frameworks in both the United States and the European Union are undergoing continuous development. In the United States, information about the device component of drug-led combination products is generally submitted through a singular marketing application, following the regulatory pathways for drugs or biologics, such as the Biologics License Application (BLA), New Drug Application (NDA), or Investigational New Drug (IND).

Drug-Device Combination Products Market- Market Dynamics

Increasing demand for minimally invasive drug delivery devices and increasing prevalence of chronic diseases such as diabetes are anticipated to drive the market.

As the prevalence of conditions such as diabetes, cardiovascular diseases, and respiratory disorders rises, there is a notable increase in the utilization of Drug-Device Combination Products to enhance treatment efficacy, patient compliance, and overall healthcare results. With the growing population of patients requiring long-term medication management, the use of Drug-Device Combination Products, such as insulin pumps, auto-injectors, and prefilled syringes, is on the rise to improve treatment effectiveness and patient adherence. A study conducted by the American Diabetes Association included 96,547 patients with type 1 diabetes across 432 diabetes centers. Additionally, advancements in technology, along with increasing regulatory support and approvals, may present opportunities for market expansion. Nevertheless, high manufacturing and development costs could pose challenges to market growth.

Drug-Device Combination Products Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.9% over the forecast period (2025-2032)

Based on product type segmentation, Transdermal Patches was predicted to show maximum market share in the year 2024

Based on Application segmentation, Cardiovascular was the leading Application in 2024

Based on End-User segmentation, the hospital was the leading End-User in 2024

Based on region, North America was the leading revenue generator in 2024

Drug-Device Combination Products Market- Segmentation Analysis:

The Global Drug Device Combination Products Market is segmented based on Product Type, Application, End-User, and Region.

The market is categorized into five segments according to product type: Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others. Transdermal Patches are at the forefront of market growth. The Drug-Device Combination Products Market is witnessing significant expansion, propelled by innovations in transdermal drug delivery systems. Transdermal patches, a vital component of this sector, facilitate controlled drug release, enhance patient adherence, and mitigate systemic side effects when compared to oral or injectable options. Regulatory approvals from the FDA and EMA for next-generation patches are contributing to market growth. Additionally, the development of biocompatible and biodegradable patches aims to reduce skin irritation.

The market is classified into four primary categories based on application: Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, and Other. The Cardiovascular segment leads the market. The Drug-Device Combination Products Market is experiencing substantial growth, especially within the cardiovascular segment, driven by the rising incidence of heart diseases and the growing need for sophisticated, minimally invasive treatment options. These products integrate pharmaceuticals with medical devices to improve therapeutic results, enhance patient adherence, and shorten hospital stays.

The market is categorized into two segments based on End-User: Hospitals, Ambulatory Surgical Centers, and Others. The hospital segment is the leading sector within this market. The Drug-Device Combination Products Market is experiencing rapid growth, with hospitals significantly contributing to this trend due to the increasing demand for advanced, efficient, and minimally invasive treatment options. These products combine pharmaceuticals with medical devices, thereby improving therapeutic effectiveness, patient adherence, and operational efficiency within hospital settings. High-precision drug administration is essential for patients in critical care, making hospitals the primary end-users of these combination products, which are vital for critical care, surgical procedures, and the management of chronic diseases. Furthermore, hospitals are increasingly adopting minimally invasive techniques, which has led to a rise in the use of drug-eluting stents and catheter-based drug delivery systems.

Drug Device Combination Products Market- Geographical Insights

North America leads in market growth, attributed to its advanced healthcare infrastructure and significant research and development activities. The region benefits from a robust regulatory framework and advantageous reimbursement policies, which further facilitate market growth. In 2022, health expenditures in the United States rose by 4.1%, reaching USD 4.5 trillion, or USD 13,493 per capita. This growth rate aligns with pre-pandemic figures, as reported by the American Medical Association. Meanwhile, countries such as China, Japan, and India are witnessing a growing demand for drug-device combination products, driven by the rising incidence of chronic diseases. Additionally, the UAE and South Africa represent important markets due to their increased investments in medical innovation.

Drug-Device Combination Products Market- Competitive Landscape:

The Drug-Device Combination Products Market is highly competitive, with key players focusing on technological advancements, regulatory approvals, and strategic collaborations to strengthen their market position. The competition is driven by the rising demand for advanced drug delivery systems, the increasing prevalence of chronic diseases, and the growing preference for minimally invasive treatments. Companies compete by developing next-generation drug-device combinations that enhance patient convenience and therapeutic efficacy. Major companies are expanding into emerging markets (Asia-Pacific, Latin America, and the Middle East) due to increasing healthcare investments.

Recent Developments:

In May 2024, Novartis announced that it had reached an agreement to acquire Mariana Oncology, a biotechnology firm in the preclinical stage located in Watertown, Massachusetts. The company specializes in the development of innovative radio ligand therapies (RLTs) aimed at addressing cancers that present significant unmet medical needs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp.
  • Becton
  • Dickinson and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • AbbVie Inc. (Allergan)
  • W. L. Gore & Associates Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Others

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug Eluting Stents
  • Infusion Pumps
  • Inhalers
  • Orthopedic Combination Products
  • Wound Care Combination Products
  • Photodynamic Therapy Devices
  • Transdermal Patches
  • Antimicrobial Catheters
  • Others

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular
  • Diabetes
  • Cancer Treatment
  • Respiratory Diseases
  • Other

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Other

GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Device Combination Products Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Drug Device Combination Products Market Snippet by Product Type
    • 2.1.2. Drug Device Combination Products Market Snippet by Application
    • 2.1.3. Drug Device Combination Products Market Snippet by End-User
    • 2.1.4. Drug Device Combination Products Market Snippet by Country
    • 2.1.5. Drug Device Combination Products Market Snippet by Region
  • 2.2. Competitive Insights

3. Drug Device Combination Products Key Market Trends

  • 3.1. Drug Device Combination Products Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Device Combination Products Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Device Combination Products Market Opportunities
  • 3.4. Drug Device Combination Products Market Future Trends

4. Drug Device Combination Products Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Device Combination Products Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Device Combination Products Market Landscape

  • 6.1. Drug Device Combination Products Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Device Combination Products Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Drug Eluting Stents
    • 7.1.3. Infusion Pumps
    • 7.1.4. Inhalers
    • 7.1.5. Orthopedic Combination Products
    • 7.1.6. Wound Care Combination Products
    • 7.1.7. Photodynamic Therapy Devices
    • 7.1.8. Transdermal Patches
    • 7.1.9. Antimicrobial Catheters
    • 7.1.10. Others

8. Drug Device Combination Products Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular
    • 8.1.3. Diabetes
    • 8.1.4. Cancer Treatment
    • 8.1.5. Respiratory Diseases
    • 8.1.6. Other

9. Drug Device Combination Products Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Other

10. Drug Device Combination Products Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Drug Device Combination Products Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Drug Device Combination Products Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Drug Device Combination Products Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Drug Device Combination Products Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Drug Device Combination Products Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Device Combination Products Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Medtronic Plc
    • 11.2.3. Boston Scientific Corp.
    • 11.2.4. Becton
    • 11.2.5. Dickinson and Company
    • 11.2.6. Novartis AG
    • 11.2.7. GlaxoSmithKline plc
    • 11.2.8. AbbVie Inc. (Allergan)
    • 11.2.9. W. L. Gore & Associates Inc.
    • 11.2.10. Stryker Corporation
    • 11.2.11. Terumo Corporation
    • 11.2.12. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us